The assessment of bone microarchitecture in vivo is of high interest in the understanding of bone metabolism. Many fields of bone research are interested in such characterization: diagnosis, treatment, and monitoring of osteoporosis, secondary osteoporosis, drug development, pediatrics, athletes, and more.The current gold standard to quantify trabecular and cortical bone microarchitecture in vivo is the high-resolution peripheral quantitative computed tomography (HR-pQCT). This technology only allows bone extremities scanning. Therefore, developing novel technologies to assess bone microarchitecture at other bone sites seems interesting. In a recent issue of JBMR, Mys and colleagues were comparing the accuracy of cone-beam computed tomography (CBCT) and HR-pQCT in regard to micro-CT for bone microarchitecture parameters. (1) They also determined the correlation of these parameters between CBCT and HR-pQCT.The original article described the technical specifications of HR-pQCT (namely XtremeCT, referred to incorrectly in the article as XtremeCT I, and Xtreme CT II) scanners, manufactured by SCANCO Medical AG (Bruttisellen, Switzerland) and CBCT (NewTom 5G, Cefla, Verona, Italy). They presented the protocol of image acquisition, reconstruction, segmentation, and analysis for all in vivo scanners in order to compare the ex vivo assessment of trabecular bone microarchitecture of 19 trapezia. The authors concluded that CBCT and its associated image processing and analysis method is able to quantify trabecular bone microstructure of trapezia.Considering the very high interest in the community in such technologies (~850 publications in the last 15 years for HR-pQCT), we propose a corrected comparison of the scanners' performances as described below. That would allow to better understand these different imaging systems and to properly evaluate the advances in this field.In the recent article by Mys and colleagues, the comparison between the specifications of the imaging modalities was unclear, as those systems allow various acquisition modes and acquisition protocols. Moreover, several figures in the article were simply inaccurate.The CBCT device NewTom 5G offers several acquisition protocols as described in an earlier study. (2) In the latter work, an effective dose of 14.3 μSv was measured using a high-resolution scanning protocol with 12 cm × 8 cm field of view (FOV), whereas Mys and colleagues reported an effective dose of 1.6 μSv without bringing evidence for this value. Also, this recent investigation was done on a smaller FOV of 6 cm × 6 cm, for which an extrapolation of the effective dose can be calculated: Assuming the distance between X-ray source and detector is constant and considering the scan length ratio, the extrapolated effective dose would be 10.7 μSv. Another group reported an effective dose of 10 μSv for a similar acquisition protocol with the same CBCT device. (3) HR-pQCT devices, namely XtremeCT and XtremeCT II, offer a standard single stack scan with a FOV of 12.6 cm × 0.9 cm and 14 cm × 1.0 cm, res...